Search results
US government to fund up to $500 mln for studies on oral, nasal COVID vaccines
Reuters· 5 days agoThe U.S. Department of Health and Human Services (HHS) said on Thursday it will provide up to $500...
Past COVID-19 infection may protect people against some common colds
Euronews via Yahoo News· 6 days agoThese vaccines, he said, are “still your best defence against severe COVID-19 infection,...
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines | Investing.com
Investing.com· 2 days agoStocks Analysis by MarketBeat.com (Jea Yu) covering: Merck & Company Inc, Amgen Inc, Biogen Inc,...
FDA reverses course, calls for vaccines for fall 2024 to target newer COVID-19 strain
Scripps News via AOL· 5 days agoThe FDA is reversing course on its COVID vaccine guidance: Rather than having a vaccine that targets...
FDA recommends COVID jab manufacturers update formulas to combat new strain
BizPac Review· 4 days agoThe U.S. Food and Drug Administration (FDA) announced Thursday that manufacturers of the COVID vaccines should focus on the KP.2 strain of the JN.1 variant ...
Here are 7 things Arizonans need to know about the new KP.3 variant of COVID-19
The Arizona Republic· 7 days agoA new variant of COVID-19 called KP.3 is on the rise in the U.S. and has been detected in Arizona....
Past COVID infections may help protect against certain colds. Could it lead to better vaccines?
San Francisco Chronicle· 7 days agoA new study suggests previous COVID-19 infections lower the risk of getting colds caused by milder...
Dr. Anthony Fauci says empathy motivated his medical career but an old phrase from high school kept...
CNN.com· 13 hours agoThat phrase, instilled in Dr. Anthony Fauci when he was a student at the Jesuit-run Regis High...
Past COVID infections may help protect against certain colds. Could it lead to better vaccines?
KAAL Austin· 7 days agoA new study suggests previous COVID-19 infections lower the risk of getting colds caused by milder...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks· 4 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared ...